Chris Markoch

Chris Markoch

InvestorPlace Contributor

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

Now Is Not a Time to Gamble on Electrameccanica Vehicles

By Chris Markoch, InvestorPlace Contributor

SOLO stock is soaring as Electrameccanica Vehicles prepares to open a U.S. manufacturing facility. But the question remains if the company is a fad?

5 Index Funds That Belong In Any Portfolio Seeking Diversification

By Chris Markoch, InvestorPlace Contributor

Index funds are an ideal way for risk-averse investors to diversify and improve their total return. These five funds have been among the best performers.

Hyliion Has One Giant Problem Between Its Vision and Its Reality

By Chris Markoch, InvestorPlace Contributor

Hyliion stock is the latest EV stock to go public in 2020. The company has ambitious goals, but the company's niche market already looks small.

Make Ever-Glory International Give You a Reason to Buy its Stock

By Chris Markoch, InvestorPlace Contributor

EVK stock is up over 100% in the last month. The question is why. And if the answer is "because it's 2020", that's not a reason to buy it.

Care to Place a Bet on DraftKings?

By Chris Markoch, InvestorPlace Contributor

After a stellar earnings report, DraftKings stock looks ready to soar. However with uncertainty about virus-related shutdowns, caution is warranted.

Without Real Numbers to Judge, It’s More of the Same for Luckin Stock

By Chris Markoch, InvestorPlace Contributor

Investors hope Luckin stock is free of accounting fraud. But until it reports earnings, investors should assume nothing has changed.

Know Why You’re Buying (Or Not Buying) Palantir Technologies

By Chris Markoch, InvestorPlace Contributor

PLTR stock is seeing a post-election bounce which indicates that this controversial company can do business on both sides of the aisle.

Can Inovio Benefit From All Of Its Vaccine Delays?

By Chris Markoch, InvestorPlace Contributor

Shares of Inovio (NASDAQ:INO) are trading near a six-month low. The company is being battered by delays in getting its Covid-19 vaccine candidate into Phase…

The Law of Diminishing Returns Makes Sunrun Stock Look a Lot Riskier

By Chris Markoch, InvestorPlace Contributor

The affordability and demand for solar is a catalyst for Sunrun stock. But as analyst coverage increases, the growth forecast is getting weaker.

5 Vice ETFs For Safe Investment In Sin Stocks

By Chris Markoch, InvestorPlace Contributor

It's been an uneven year for sin stocks. But investors are optimistic that 2021 will be better, and these vice ETFs are great for exposure.

Load More